What Happened?
, -based Prime Medicine Appointed Allan Reine as Chief Financial Officer
About the Company
Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations.
About the Person
Allan Reine is Chief Financial Officer at Prime Medicine. Previously, Allan held various senior HR leadership roles in the industry.
Info Source
News
Short Profile